pSivida: One Step Away from Upgrading the Stock (PSDV, Hold, $2.80))Thursday, February 18, 2016 · 7:16 am |
|
The BIO CEO Conference: Highlights from the Meeting and New Investment Perspectives (Subscribers Only)Friday, February 14, 2014 · 4:28 pm |
|
pSivida: Why I Think the Stock Could Do Very Well in 2014 (PSDV, $4.12) (Subscribers Only)Friday, January 10, 2014 · 1:10 pm |
|
pSivida: Game On for Iluvien (PSDV, $4.29)Thursday, December 19, 2013 · 12:02 pm |
|
How Iluvien May Benefit Alimera and pSivida (PSDV, $3.25)Friday, May 31, 2013 · 1:22 pm |
|
|
There are 5 reports on file. |
